Many With Sleep Apnea Also Suffer From GI Tract Conditions
Posted on: Monday, 5 October 2009, 06:10 CDT
Patients who suffer from obstructive sleep apnea (OSA) also tend to have additional gastrointestinal (GI) tract conditions, such as gastric reflux and hiatal hernia, which form at the opening in your diaphragm where your food pipe (esophagus) joins your stomach.
In a paper presented at the 2009 American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO in San Diego, researchers analyzed prospective clinical study data of 42 adult patients with proven OSA verified in overnight polysomnography. Every patient also underwent an upper GI endoscopy to evaluate their gastrointestinal health.
Pathological GI findings were found in vast majority of patients (83.3 percent), 59.5 percent of them showing two or more findings. The most frequent observed pathology was hiatus hernia (64.3 percent of patients), followed by erosive esophagitis (45.2 percent), histological esophagitis and erosive gastritis (both 21.4 percent), duodenal ulcer (7.1 percent), and biliary reflux (4.8 percent).
Approximately 12 million Americans have sleep apnea. Sleep apnea is characterized by episodes of reduced or no airflow throughout the night.
From their findings, the authors conclude that patients who appear to suffer from OSA should not only be investigated in sleep laboratory, but should also be referred to a gastroenterologist for additional diagnostic exams in order to provide a comprehensive treatment approach.
Title: Gastrointestinal findings in obstructive sleep apnea patient
Presenters: Nora Siupsinskiene, MD, PhD, Kestutis Adamonis, MD, and Robert Toohill, MD
---
On the Net:
Related Articles
- DaVita Offers Dialysis While Patients Sleep
- Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring, Finds Frost & Sullivan
- Surveyed Neurologists in Both the United States and Europe Indicate That a Once-Daily Transdermal Formulation of Levodopa Would Earn a 30 Percent Patient Share in Parkinson's Disease
- A Drug That Improves Exercise Capacity By a Greater Percentage Than Tracleer Would Earn a 48 Percent Patient Share in the Pulmonary Arterial Hypertension Market
- A Weight Neutral Oral Antidiabetic Drug Would Earn a 25 Percent Patient Share in the Type 2 Diabetes Drug Market
- A Drug With Efficacy Superior to That of Remicade at Inducing Closure and Healing of Fistulas Would Earn a 30 Percent Patient Share in the Crohn's Disease Drug Market
- AstraZeneca's Recentin Plus FOLFOX4 to Earn 10 Percent Patient Share in the Treatment of Colorectal Cancer By 2016
- AstraZeneca's Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer By 2016
- Study Published in CHEST - The Cardiopulmonary and Critical Care Journal Finds Apnea Risk Evaluation System an Accurate and Cost-Effective Alternative to Polysomnography
- UCLA Researchers Find Common Gastrointestinal Condition Keeps Patients Up At Night
 |
 |
User Comments (0)
RSS Feeds